BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 27543694)

  • 21. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of
    Li Y; Angelova A; Hu F; Garamus VM; Peng C; Li N; Liu J; Liu D; Zou A
    Langmuir; 2019 Nov; 35(45):14532-14542. PubMed ID: 31635451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
    Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
    Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
    Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
    J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfide-cross-linked PEG-block-polypeptide nanoparticles with high drug loading content as glutathione-triggered anticancer drug nanocarriers.
    Chen YF; Chang CH; Lin CY; Lin LF; Yeh ML; Jan JS
    Colloids Surf B Biointerfaces; 2018 May; 165():172-181. PubMed ID: 29482128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells.
    Imanimoghadam M; Yaghoobi E; Alizadeh F; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    J Pharm Sci; 2024 Jul; 113(7):1865-1873. PubMed ID: 38342338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simply constructed chitosan nanocarriers with precise spatiotemporal control for efficient intracellular drug delivery.
    Kong M; Zuo Y; Wang M; Bai X; Feng C; Chen X
    Carbohydr Polym; 2017 Aug; 169():341-350. PubMed ID: 28504154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
    Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
    Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer.
    Saxena V; Diaz A; Clearfield A; Batteas JD; Hussain MD
    Nanoscale; 2013 Mar; 5(6):2328-36. PubMed ID: 23392208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells.
    Luesakul U; Puthong S; Neamati N; Muangsin N
    Carbohydr Polym; 2018 Feb; 181():841-850. PubMed ID: 29254044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy.
    Niu S; Williams GR; Wu J; Wu J; Zhang X; Chen X; Li S; Jiao J; Zhu LM
    J Nanobiotechnology; 2019 Sep; 17(1):95. PubMed ID: 31506085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabrication of pH-Responsive Nanoparticles with an AIE Feature for Imaging Intracellular Drug Delivery.
    Wang X; Yang Y; Zhuang Y; Gao P; Yang F; Shen H; Guo H; Wu D
    Biomacromolecules; 2016 Sep; 17(9):2920-9. PubMed ID: 27442328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate.
    Macedo LB; Nogueira-Librelotto DR; de Vargas J; Scheeren LE; Vinardell MP; Rolim CMB
    AAPS PharmSciTech; 2019 Apr; 20(5):165. PubMed ID: 30993464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facile solvothermal synthesis of mesostructured Fe3O4/chitosan nanoparticles as delivery vehicles for pH-responsive drug delivery and magnetic resonance imaging contrast agents.
    Zhao G; Wang J; Peng X; Li Y; Yuan X; Ma Y
    Chem Asian J; 2014 Feb; 9(2):546-53. PubMed ID: 24259489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.